A Ardura-Fabregat, E Boddeke, A Boza-Serrano… - CNS drugs, 2017 - Springer
Over the past few decades, research on Alzheimer's disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular …
X Hu, GL Zhao, MX Xu, H Zhou, F Li, Y Miao… - Journal of …, 2021 - Springer
Background Glaucoma, the leading cause of irreversible blindness, is a retinal neurodegenerative disease, which results from progressive apoptotic death of retinal …
B Pál - Cellular and Molecular Life Sciences, 2018 - Springer
Glutamate is the most abundant neurotransmitter of the central nervous system, as the majority of neurons use glutamate as neurotransmitter. It is also well known that this …
C Agulhon, MY Sun, T Murphy, T Myers… - Frontiers in …, 2012 - frontiersin.org
A prominent area of neuroscience research over the past 20 years has been the acute modulation of neuronal synaptic activity by Ca2+-dependent release of the transmitters ATP …
SF Spampinato, A Copani, F Nicoletti… - Frontiers in molecular …, 2018 - frontiersin.org
Neurodegenerative disorders are characterized by excitotoxicity and neuroinflammation that finally lead to slow neuronal degeneration and death. Although neurons are the principal …
M Lee - Current Protein and Peptide Science, 2013 - ingentaconnect.com
Reciprocal interactions between cells caused by release of soluble factors are essential for brain function. So far, little attention has been paid to interactions between neurons and glia …
T A. Kato, Y Yamauchi, H Horikawa… - Current medicinal …, 2013 - benthamdirect.com
Psychiatric disorders have long and dominantly been regarded to be induced by disturbances of neuronal networks including synapses and neurotransmitters. Thus, the …
RF Budgett, G Bakker, E Sergeev, KA Bennett… - Frontiers in …, 2022 - frontiersin.org
The type 5 metabotropic glutamate receptor, mGlu5, has been proposed as a potential therapeutic target for the treatment of several neurodegenerative diseases. In preclinical …
Traumatic brain injury (TBI) induces microglial activation, which can contribute to secondary tissue loss. Activation of mGluR5 reduces microglial activation and inhibits microglial …